Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2007
10/25/2007US20070250960 Generation of Plants with Altered Oil Content
10/25/2007US20070250959 Maize promoter active in silks, stalk nodes, roots and leaf sheaths
10/25/2007US20070250958 Cotton Cultivar PM 3535 BG/RR
10/25/2007US20070250957 Group III nitride semiconductor light emitting device having a light emitting layer (6) bonded to a crystal layer composed of an n-type or p-type Group III nitride semiconductor, the Group III nitride semiconductor light emitting device being characterized by comprising an n-type Group III nitride
10/25/2007US20070250955 Plants and seeds of corn variety i796483
10/25/2007US20070250954 Plants and seeds of corn variety i285290
10/25/2007US20070250953 Plants and seeds of corn variety i877879
10/25/2007US20070250952 Plants and seeds of corn variety i112311
10/25/2007US20070250951 Plants and seeds of corn variety i226276
10/25/2007US20070250950 Plants and seeds of corn variety i291273
10/25/2007US20070250949 Plants and seeds of corn variety i286346
10/25/2007US20070250948 Vectors useful in plant transformations; useful for transferring and integrating one polynucleotide into another via bacterial-mediated transformation
10/25/2007US20070250946 Monocot Ahass Sequences and Methods of Use
10/25/2007US20070250945 Usage of Mad-Box Genes in Fruit & Seed Development by Regulating Active Gibberellin Synthesis
10/25/2007US20070250943 Construction of Chimera Using En Cells
10/25/2007US20070250940 Transgenic mice for bioassay of prions from deer and elk with chronic wasting disease
10/25/2007US20070249820 Activatable Ribozymal Purification Constructs and Methods of Use
10/25/2007US20070249819 siRNA targeting WEE1 homolog (WEE1)
10/25/2007US20070249814 Transcriptional regulatory factor
10/25/2007US20070249813 recombinant human antibodies containing CDR3 domain having an amino acid sequence with alanine substitutions that specifically bind to human tumor necrosis factor alpha (hTNF alpha ) to treat autoimmune disorders ( rheumatic arthritis, allergy, multiple sclerosis, autoimmune diabetes)
10/25/2007US20070249783 Polyamide Resin and Hinged Molded Product
10/25/2007US20070249553 Vaccine And Nucleic Acids Capable Of Protecting Poultry Against Colonisation By Campylobacter
10/25/2007US20070249552 Compositions and Methods for Sirna Inhibition of Primate Polyomavirus Genes
10/25/2007US20070249551 Compositions and methods for non-parenteral delivery of oligonucleotides
10/25/2007US20070249549 Compounds and Methods for Rna Interference of the P65 Subunit of Nf-Kappa-B
10/25/2007US20070249539 Vascular endothelial growth factor; hypoxia responsive element; amyotrophic lateral sclerosis
10/25/2007US20070249538 tumor necrosis factor (TNF) antagonists and corresponding nucleic acids; inflammatory diseases; the proteins lack exon 7 and which can bind TNF and can act as a TNF antagonist
10/25/2007US20070249533 Il-17a and il-17f antagonists and methods of using the same
10/25/2007US20070249530 Bcma Polypeptides and Uses Thereof
10/25/2007US20070249521 polypeptide having antimicrobial activity, having an amino acid sequence selected from e.g. Arg Arg Arg Pro Pro Arg Leu Pro Arg Pro Phe Pro; Phe Arg Pro Pro Pro Arg Pro Arg Pro Leu Pro Val; detergents, animal feed
10/25/2007US20070249043 Adenoviral expression vectors
10/25/2007US20070249042 Strains of E. Coli for Plasmid Dna Production
10/25/2007US20070249032 Flavivirus vaccine
10/25/2007US20070249028 Aerobic Succinate Production in Bacteria
10/25/2007US20070249023 Process for immobilizing cells on a resin
10/25/2007US20070249022 Osteoporosis; transforming growth factors; pyrogen-free
10/25/2007US20070249020 Cytokine zcytor17 ligand polypeptides and polynucleotides
10/25/2007US20070249017 Polynucleotides Encoding Polypeptides Involved in Amino Acid Biosynthesis in Methylophilus Methylotrophus
10/25/2007US20070249016 Method for Gene Amplification
10/25/2007US20070249011 Method for Screening Fungus-Specific Antimicrobial Agent and Kit Therefor
10/25/2007US20070249009 Compositions and methods for altering RNAi
10/25/2007US20070249004 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents; exposing a GSK3- beta molecule to a putative inhibitor, and measuring the specific enzymatic activity of said GSK3- beta molecule
10/25/2007US20070248995 Molecules
10/25/2007US20070248982 Automatic threshold setting and baseline determination for real-time PCR
10/25/2007US20070248975 Methods for monitoring the expression of alternatively spliced genes
10/25/2007US20070248972 Page-4, an X-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
10/25/2007US20070248957 Encoded solid supports for biological processing and assays using same
10/25/2007US20070248945 Stem cells derived from uniparental embryos and methods of use thereof
10/25/2007US20070248686 Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same
10/25/2007US20070248679 Vaccine
10/25/2007US20070248627 Gene Therapy for Tumors Using Minus-Strand Rna Viral Vectors Encoding Immunostimulatory Cytokines
10/25/2007US20070248626 Recombinant toxin fragments
10/25/2007US20070248623 Gene Construction, Vector and Dna Vaccine for the Vaccination of Aquatic Animals
10/25/2007US20070248616 Canine Respiratory Coronavirus (Crcv) Spike Protein, Polymerase and Hemagglutinin/Esterase
10/25/2007US20070248613 Human Antibodies Interacting with Hiv Gp41
10/25/2007US20070248608 Monoclonal Antibodies to Progastrin
10/25/2007US20070248606 Treatment of Alzheimer's disease
10/25/2007US20070248604 Inhibits fibroblast growth factor (FGF); used to treat a tumor, a cancer, and/or a cell proliferative disorder
10/25/2007US20070248601 Non-Human Transgenic Mammal for the Constant Region of the Class a Human Immunoglobulin Heavy Chain and Applications Thereof
10/25/2007US20070248598 Recombinant anti-VLA4 antibody molecules
10/25/2007US20070248596 Transgenic Ficus, Method for Producing Same and Use Thereof
10/25/2007US20070248593 Identifying and characterizing novel human secreted proteins and their genes ; promotes vascularization; screening methods
10/25/2007US20070248588 Novel Compositions and Methods for the Treatment of Immune-Related Diseases
10/25/2007US20070248543 Chicken Deoxycytidine and Deoxyadenosine Kinase Enzymes and Their Use
10/25/2007DE102006018583A1 Abwehrstoff gegen die Bildung von Haustorien als Pflanzenschutzmittel gegen Pflanzenparasiten Antitoxin against the formation of haustoria as plant protection agents against plant parasitic
10/25/2007DE10100305B4 Knorpelzellmarker, Verfahren sowie Verwendungen desselben The same chondrocyte marker, processes and uses
10/25/2007CA2650126A1 Methods of treating, diagnosing or detecting cancer
10/25/2007CA2650061A1 Method for modifying the atp/adp ratio in cells
10/25/2007CA2649698A1 Whole genome evolution technology applied to improve protein and antibody yields by cells
10/25/2007CA2649661A1 Influenza virus vaccine
10/25/2007CA2649431A1 N protein fusion proteins of a virus in the paramyxoviridae-protein of interest family and their use for intracellular vectorization and vaccination
10/25/2007CA2649326A1 Targeted binding agents directed to upar and uses thereof
10/25/2007CA2649325A1 Kits and methods for generating 5' capped rna
10/25/2007CA2649269A1 Protein complex and process for producing the same
10/25/2007CA2649250A1 Dopaminergic neuron progenitor cell marker 187a5
10/25/2007CA2649148A1 Taurine transporter gene
10/25/2007CA2649114A1 Compositions and methods for modulating gene expression
10/25/2007CA2648926A1 Cellulase fusion proteins and their use
10/25/2007CA2648748A1 Nitrogen-containing heterocyclic compound
10/25/2007CA2648263A1 Permuted and nonpermuted luciferase biosensors
10/25/2007CA2647944A1 Active potassium channel transporters (akt) and their use to create stress tolerant plants
10/25/2007CA2647580A1 Method for measuring human megalin
10/25/2007CA2647520A1 Method and apparatus of low strengh electric field network-mediated delivery of drug, gene, sirna, shrn, protein, peptide, antibody or other biomedical and therapeutic molecules and reagents in skin, soft tissue, joints and bone
10/25/2007CA2646586A1 Methods and means for assessing hiv gag/protease inhibitor therapy
10/25/2007CA2646253A1 Method for cloning and expression of nrui restriction endonuclease
10/25/2007CA2645766A1 Immunogenic wt-1 peptides and methods of use thereof
10/25/2007CA2633887A1 Methods and compositions for targeting polyubiquitin
10/24/2007EP1847620A2 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
10/24/2007EP1847619A2 High throughput assay system
10/24/2007EP1847614A1 Compositions for delivering enzymes involved in amino acid metabolism using recombinant adeno-associated virus virions (raav virions), and method and use for treating amino acid metabolic disorders using such raav virions
10/24/2007EP1847613A2 Suppression of specific classes of soybean seed protein genes
10/24/2007EP1847612A1 Expression of modified antibodies in avian cells
10/24/2007EP1847611A2 Rhamnose-inducible expression system
10/24/2007EP1847610A2 Maize cellulose synthases and uses thereof
10/24/2007EP1847609A1 BASB205 polypeptides and polynucleotides coding therefor
10/24/2007EP1847608A1 Member of the TNF ligand family
10/24/2007EP1847607A1 Human p51 protein and antibody
10/24/2007EP1847606A2 Mitogenic regulators
10/24/2007EP1847605A2 Methods for producing members of specific binding pairs
10/24/2007EP1847604A1 Intracellular method for selecting a peptide or polypeptide which binds to a bait peptide or polypeptide